This site is intended for Healthcare Professionals only.

Tag: breast cancer

spot_imgspot_img

NICE recommends abemaciclib for early breast cancer

The National Institute for Health and Care Excellence (NICE) has recommended abemaciclib also called Verzenios, made by Eli Lilly, for people with hormone receptor-positive,...

NICE recommends new injectable immunotherapy treatment for rare triple negative breast cancer

The National Institute for Health and Care Excellence (NICE) has recommended pembrolizumab in combination with chemotherapy (paclitaxel or nab-paclitaxel) (Injectable immunotherapy treatment) which is...

NICE recommends innovative technology to show if breast cancer has spread

The National Institute of Health and Care Excellence has recommended that surgeons working in hospitals with limited or no access to a radiopharmacy department...

NICE says ‘highly effective’ breast cancer drug is ‘too expensive’ for NHS use

Sacituzumab govitecan, a 'highly effective' treatment for triple negative breast cancer, is not recommended by the National Institute for Health and Care Excellence (NICE)...

NICE recommends tucatinib for advanced breast cancer

NICE has recommended use of tucatinib as an option to treat HER2-positive breast cancer that has spread in people who have already tried 2...

New study: Aspirin to be trialled as part of new treatment for breast cancer

A new groundbreaking study is undergoing to find whether giving aspirin, commonly used as pain relief, alongside immunotherapy drug avelumab could improve its effectiveness...